Siga Technologies (SIGA) Cash from Operations (2010 - 2025)
Siga Technologies' (SIGA) quarterly Cash from Operations came in at 9814444.0 in Q3 2025, down 32.92% YoY from 14631941.83 in Q3 2024, and down 115.56% on a QoQ basis from 63084829.0 in Q2 2025.
Siga Technologies (SIGA) Cash from Operations (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has 16 years of Cash from Operations data on file, last reported at 9814444.0 in Q3 2025.
- Quarterly Cash from Operations fell 32.92% year-over-year to 9814444.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 116642361.0 (up 63.17% YoY) and the FY2024 annual result came in at 48761807.0, down 48.56% from the prior year.
- Cash from Operations fell to 9814444.0 in Q3 2025, from 63084829.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 79031730.0 in Q4 2023 to a low of 9814444.0 in Q3 2025.
- A 5-year average of 13526268.26 and a median of 1430272.0 in 2021 frame the typical range for Cash from Operations.
- The widest YoY moves for Cash from Operations: up 1279.83% in 2022, down 393.58% in 2022.
- Tracing SIGA's Cash from Operations over 5 years: stood at 16102562.0 in 2021, then slumped by 150.34% to 8106225.0 in 2022, then soared by 1074.95% to 79031730.0 in 2023, then fell by 28.75% to 56310100.0 in 2024, then slumped by 117.43% to 9814444.0 in 2025.
- The last three Cash from Operations figures came in at 9814444.0 (Q3 2025), 63084829.0 (Q2 2025), and 7061876.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Siga Technologies | 210.16 Mn | 55.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -9.81 Mn |
| Sep 30, 2025 | -9.81 Mn |
| Jun 30, 2025 | 63.08 Mn |
| Jun 30, 2025 | 63.08 Mn |
| Mar 31, 2025 | 7.06 Mn |
| Mar 31, 2025 | 7.06 Mn |
| Dec 31, 2024 | 56.31 Mn |
| Dec 31, 2024 | 56.31 Mn |
| Sep 30, 2024 | -7.38 Mn |
| Sep 30, 2024 | -7.38 Mn |
| Jun 30, 2024 | 5.95 Mn |
| Jun 30, 2024 | 5.95 Mn |
| Mar 31, 2024 | -6.12 Mn |
| Mar 31, 2024 | -6.12 Mn |
| Dec 31, 2023 | 79.03 Mn |
| Dec 31, 2023 | 79.03 Mn |
| Sep 30, 2023 | -5.10 Mn |
| Sep 30, 2023 | -5.10 Mn |
| Jun 30, 2023 | -3.58 Mn |
| Jun 30, 2023 | -3.58 Mn |